Pharma Mar SA is a Spain-based company engaged in the bio therapeutic drugs manufacture. The Company focuses on research, development and marketing of bio-active principles, primarily from marine origin, for application in human diseases treatment, including antitumour, antiviral and immunomodulation, as well as tropical diseases areas. It manufactures and sells Yondelis, a synthetically modified antitumor agent, which is derived from sea squirts and is implemented in the treatment of soft tissue sarcomas and relapsed ovarian cancer. Furthermore, the Company's products pipeline comprises drug candidates and agents for cancer treatment, such as Aplidin, PM01183 and PM060184. The Company operates through subsidiaries in Italy, Germany, France, and the United States, among others.
|Juan Carlos Villalon Gomez||-||-||Internal Auditor|
|Ali Zeaiter||-||2018||Director of Clinical Development|
|Alfonso Ortin||-||2016||Director of Communications|
|Belen Sopesen Veramendi||-||-||Director of Market Research and Development|
|Jose Luis Ortega Conejero||-||2004||Director of Quality Unit|
|Luis Mora Capitan||-||-||Managing Director of Oncology Business Unit|
|Ana Belen Irigaray Huarte||-||2014||Director of Corporate Regulatory Affairs|
|Elena Calleja Crespo||-||2008||Director of Finance - Oncology Business Unit|
|Pascal M. Besman||-||-||Chief Operating Officer of PharmaMar U.S.|
|Pedro Berbil Bautista||-||2004||Director of Industrial Operations|
|Jose Luis Moreno Martinez-Losa||-||-||Director of Investor Relations and Capital Markets|
|Juan Nogues Ortuno||-||2013||Director of International Sales and Marketing|
|Sebastian Cuenca Miranda||-||-||General Counsel, Secretary|
|Jose Maria Fernandez Sousa-Faro||-||-||President, Chief Executive Officer, Executive Chairman of the Board|
|Pedro Fernandez Puentes||-||-||Executive Vice Chairman|
|Maria Luisa de Francia Caballero||-||-||Chief Financial Officer|
|Luis Ruperez Cuenca||-||-||Director of Human Resources and IT|
|Nadia Badri||-||2011||Vice President - Medical Affairs|
|Heiner Pieper||-||2013||Vice President - Business Development & Licensing|
|Carmen Cuevas Marchante||-||2003||Director of Research & Development|
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.